e-Book
While passive cardiovascular implants might look simple on the outside, they are challenging to develop, manufacture, and implant. These devices must function under different physiological conditions while sustaining performance throughout their intended life cycle and work for a variety of patient demographics. They also must undergo rigorous regulatory approval before reaching the market.
With so many variables, it is easy for production and regulatory approval processes to be delayed, which ultimately postpones access to these lifesaving devices for those who need them most. Computational modeling and simulation (CM&S) offers a solution to address these challenges by enabling medical device manufacturers to accelerate product development and approval while reducing uncertainty and maintaining safety.
Read the e-book to learn how in silico solutions address some of the most common challenges manufacturers face while developing passive cardiovascular devices.
SHARE THIS E-BOOK
现在就开始行动吧！
如果您面临工程方面的挑战，我们的团队将随时为您提供帮助。我们拥有丰富的经验并秉持创新承诺，期待与您联系。让我们携手合作，将您的工程挑战转化为价值增长和成功的机遇。欢迎立即联系我们进行交流。